Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON25161
NL-OMON25161
Not Yet Recruiting
N/A

A double-blind, placebo controlled, randomized study comparing the effects of amitriptyline on dyspeptic symptoms in patients with functional dyspepsia.

Academic Medical Center (AMC) Amsterdam, Department gastroenterology0 sites220 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsfunctional dyspepsia

Overview

Phase
N/A
Intervention
Not specified
Conditions
functional dyspepsia
Sponsor
Academic Medical Center (AMC) Amsterdam, Department gastroenterology
Enrollment
220
Status
Not Yet Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Academic Medical Center (AMC) Amsterdam, Department gastroenterology

Eligibility Criteria

Inclusion Criteria

  • •1\. Age 18\-65 years;
  • •2\. Functional dyspepsia (NDI\>25\);
  • •3\. No effect on PPI, or 3 months constantly the same dose of PPI;
  • •4\. No medications which influence the intestine;
  • •5\. No depression (ZUNG \< 50\).

Exclusion Criteria

  • •1\. Gastroduodenal surgery in history;
  • •2\. Reflux\-like dyspepsia (Rome II criteria);
  • •3\. Use of anitdepressivants;
  • •4\. Organic abnormalities;
  • •5\. Severe cardiac, renal, pulmonary, hepatic or systemic diseases;
  • •6\. Hyperthyroidism;
  • •7\. Glaucoma and epilepsy.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
N/A
The FCATFibromyalgia
NL-OMON28585eiden University Medical Center (LUMC)40
Recruiting
N/A
The LCAT studyow back pain
NL-OMON26947eiden University Medical Center (LUMC)40
Not Yet Recruiting
N/A
A study to investigate efficacy, safety and tolerability of a medicin (risperidone) in treatment of aggression in children and adolescents.Conduct DisorderChildrenAdolescentsAggressionRisperidoneEfficacySafetyTolerabilityAgressie KinderenAdolescentenRisperidonMedicatieEffectiviteitVeiligheid
NL-OMON21876Prof J.K. Buitelaar, Radboud University Medical Centre, Nijmegen, The Netherlands264
Recruiting
N/A
A randomised, placebo controlled double blind study to assess the efficacy of a probiotic dairy product containing Lactobacillus casei Shirota on symptoms, visceroperception and inflammation in Irritable Bowel Syndrome.Irritable Bowel Syndrome (IBS) = Prikkelbare Darm Syndroom (PDS).probiotics = probioticacytokine profiles = cytokine profielenvisceroperception = visceroperceptielowgrade inflammation = laaggradige ontsteking
NL-OMON20968Yakult Honsha Co. Ltd.1-19, 1 Chome, Higashi-ShinbashiMinato-ku 105-8660Tokyo JAPANContact person: Mr OosawaContact person in Europe: Dr S Kudo or Dr J Zhao, science managerScience department of Yakult Europe B.V.Yakult Europe B.V.Schutsluisweg 11332 EN ALMEREThe Netherlands0031(0)36521130060
Completed
N/A
Randomized, double blind, placebo controlled trial of intramyocardial injection of autologous bone marrow cells in no-option patients with refractory angina pectoris and documented ischemia.Refractory angina pectoris and documented myocardial ischemia.
NL-OMON29227Departmartement of Cardiology,Leiden University Medical Center ,Leiden, the Netherlands50